These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27494845)

  • 1. Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma.
    Ramakrishnan V; Gomez M; Prasad V; Kimlinger T; Painuly U; Mukhopadhyay B; Haug J; Bi L; Rajkumar SV; Kumar S
    Oncotarget; 2016 Aug; 7(35):56253-56265. PubMed ID: 27494845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cells.
    Chen KF; Lin JP; Shiau CW; Tai WT; Liu CY; Yu HC; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Aug; 84(3):268-77. PubMed ID: 22580047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 inhibition by PU-H71 induces apoptosis through endoplasmic reticulum stress and mitochondrial pathway in cancer cells and overcomes the resistance conferred by Bcl-2.
    Gallerne C; Prola A; Lemaire C
    Biochim Biophys Acta; 2013 Jun; 1833(6):1356-66. PubMed ID: 23485394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of chemotherapeutic drugs in lymphoma cells are associated with down-regulation of inhibitor of apoptosis proteins (IAPs), prostate-apoptosis-response-gene 4 (Par-4), death-associated protein (Daxx) and with enforced caspase activation.
    Chow KU; Nowak D; Boehrer S; Ruthardt M; Knau A; Hoelzer D; Mitrou PS; Weidmann E
    Biochem Pharmacol; 2003 Sep; 66(5):711-24. PubMed ID: 12948851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined the SMAC mimetic and BCL2 inhibitor sensitizes neoadjuvant chemotherapy by targeting necrosome complexes in tyrosine aminoacyl-tRNA synthase-positive breast cancer.
    Lee KM; Lee H; Han D; Moon WK; Kim K; Oh HJ; Choi J; Hwang EH; Kang SE; Im SA; Lee KH; Ryu HS
    Breast Cancer Res; 2020 Nov; 22(1):130. PubMed ID: 33239070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma.
    Ramakrishnan V; Painuly U; Kimlinger T; Haug J; Rajkumar SV; Kumar S
    Leukemia; 2014 Jul; 28(7):1519-28. PubMed ID: 24402161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide in multiple myeloma cells via stress-mediated pathways.
    Doudican NA; Wen SY; Mazumder A; Orlow SJ
    Oncol Rep; 2012 Nov; 28(5):1851-8. PubMed ID: 22922937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 15d-PGJ
    Sperandio M; Demasi APD; Martinez EF; Saad SO; Pericole FV; Vieira KP; Freitas NS; Araújo VC; Brown AL; Clemente-Napimoga JT; Napimoga MH
    Exp Mol Pathol; 2017 Jun; 102(3):434-445. PubMed ID: 28506771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of Mcl-1 and disruption of the Mcl-1/Bak interaction in myeloma cells couple ER stress to mitochondrial apoptosis.
    Gomez-Bougie P; Halliez M; Moreau P; Pellat-Deceunynck C; Amiot M
    Cancer Lett; 2016 Dec; 383(2):204-211. PubMed ID: 27697610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel carbohydrate-based therapeutic GCS-100 overcomes bortezomib resistance and enhances dexamethasone-induced apoptosis in multiple myeloma cells.
    Chauhan D; Li G; Podar K; Hideshima T; Neri P; He D; Mitsiades N; Richardson P; Chang Y; Schindler J; Carver B; Anderson KC
    Cancer Res; 2005 Sep; 65(18):8350-8. PubMed ID: 16166312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OBATOCLAX and ABT-737 induce ER stress responses in human melanoma cells that limit induction of apoptosis.
    Wroblewski D; Jiang CC; Croft A; Farrelly ML; Zhang XD; Hersey P
    PLoS One; 2013; 8(12):e84073. PubMed ID: 24367627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival ER chaperone BIP/Grp78 and turning on the pro-apoptotic NF-κB.
    Buontempo F; Orsini E; Lonetti A; Cappellini A; Chiarini F; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; Bertacchini J; Neri LM; McCubrey JA; Martelli AM
    Oncotarget; 2016 Jan; 7(2):1323-40. PubMed ID: 26593250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells.
    Zhao Y; Zhang E; Lv N; Ma L; Yao S; Yan M; Zi F; Deng G; Liu X; He J; Wu W; Cai Z; Yu R
    Cell Physiol Biochem; 2018; 48(2):785-800. PubMed ID: 30032136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells.
    Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S
    Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 protects hepatocytes against endoplasmic reticulum stress-induced apoptosis via protein kinase A-dependent induction of glucose-regulated protein 78 expression.
    Yang FW; Fu Y; Li Y; He YH; Mu MY; Liu QC; Long J; Lin SD
    World J Gastroenterol; 2017 Oct; 23(40):7253-7264. PubMed ID: 29142472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of IAP inhibitor LCL161 and paclitaxel on hepatocellular carcinoma cells.
    Tian A; Wilson GS; Lie S; Wu G; Hu Z; Hebbard L; Duan W; George J; Qiao L
    Cancer Lett; 2014 Sep; 351(2):232-41. PubMed ID: 24976294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IAP antagonists induce anti-tumor immunity in multiple myeloma.
    Chesi M; Mirza NN; Garbitt VM; Sharik ME; Dueck AC; Asmann YW; Akhmetzyanova I; Kosiorek HE; Calcinotto A; Riggs DL; Keane N; Ahmann GJ; Morrison KM; Fonseca R; Lacy MQ; Dingli D; Kumar SK; Ailawadhi S; Dispenzieri A; Buadi F; Gertz MA; Reeder CB; Lin Y; Chanan-Khan AA; Stewart AK; Fooksman D; Bergsagel PL
    Nat Med; 2016 Dec; 22(12):1411-1420. PubMed ID: 27841872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma.
    Abdel Malek MA; Jagannathan S; Malek E; Sayed DM; Elgammal SA; Abd El-Azeem HG; Thabet NM; Driscoll JJ
    Oncotarget; 2015 Feb; 6(5):3098-110. PubMed ID: 25605012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of PI3K/Akt signaling by synthetic bichalcone analog TSWU-CD4 induces ER stress- and Bax/Bak-mediated apoptosis of cancer cells.
    Lin ML; Chen SS; Huang RY; Lu YC; Liao YR; Reddy MV; Lee CC; Wu TS
    Apoptosis; 2014 Nov; 19(11):1637-53. PubMed ID: 25183449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.